These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 16462709
1. Evolution of glucose intolerance and diabetes in transfused patients with thalassemia. Kattamis C, Ladis V, Tsoussis D, Kaloumenou I, Theodoridis C. Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():267-71. PubMed ID: 16462709 [Abstract] [Full Text] [Related]
2. Diabetes mellitus and impaired glucose tolerance in thalassaemia major: incidence, prevalence, risk factors and survival in patients followed in the Ferrara Center. Gamberini MR, Fortini M, De Sanctis V, Gilli G, Testa MR. Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():285-91. PubMed ID: 16462713 [Abstract] [Full Text] [Related]
3. Prevalence of diabetes mellitus and impaired glucose tolerance in beta-thalassemia patients with and without hepatitis C virus infection. Mowla A, Karimi M, Afrasiabi A, De Sanctis V. Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():282-4. PubMed ID: 16462712 [Abstract] [Full Text] [Related]
4. Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping. Khalifa AS, Salem M, Mounir E, El-Tawil MM, El-Sawy M, Abd Al-Aziz MM. Pediatr Diabetes; 2004 Sep; 5(3):126-32. PubMed ID: 15450007 [Abstract] [Full Text] [Related]
5. Pancreatic iron and glucose dysregulation in thalassemia major. Noetzli LJ, Mittelman SD, Watanabe RM, Coates TD, Wood JC. Am J Hematol; 2012 Feb; 87(2):155-60. PubMed ID: 22120775 [Abstract] [Full Text] [Related]
6. Insulin resistance and beta cell function in chronically transfused patients of thalassemia major. Suvarna J, Ingle H, Deshmukh CT. Indian Pediatr; 2006 May; 43(5):393-400. PubMed ID: 16735760 [Abstract] [Full Text] [Related]
7. Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study. Mavrogiannaki A, Karamanos B, Manesis EK, Papatheodoridis GV, Koskinas J, Archimandritis AJ. J Viral Hepat; 2009 Jun; 16(6):430-6. PubMed ID: 19200136 [Abstract] [Full Text] [Related]
8. Abnormal glucose tolerance in beta-thalassemia: assessment of risk factors. Hafez M, Youssry I, El-Hamed FA, Ibrahim A. Hemoglobin; 2009 Jun; 33(2):101-8. PubMed ID: 19373585 [Abstract] [Full Text] [Related]
9. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose. Tutuncuoğlu P, Saraç F, Saygili F, Ozgen AG, Yilmaz C, Tüzün M. Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644 [Abstract] [Full Text] [Related]
10. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels. Sahin M, Karatas M, Sahin M, Ertugrul D, Kulaksizoğlu M, Dogruk A, Gokcel A, Tutuncu NB, Guvener ND, Kutlu M. Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366 [Abstract] [Full Text] [Related]
11. Glucose metabolism disorders improvement in patients with thalassaemia major after 24-36 months of intensive chelation therapy. Platis O, Anagnostopoulos G, Farmaki K, Posantzis M, Gotsis E, Tolis G. Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():279-81. PubMed ID: 16462711 [Abstract] [Full Text] [Related]
12. Epidemiology and chelation therapy effects on glucose homeostasis in thalassaemic patients. Gamberini MR, Fortini M, Gilli G, Testa MR, De Sanctis V. J Pediatr Endocrinol Metab; 1998 Dec; 11 Suppl 3():867-9. PubMed ID: 10091159 [Abstract] [Full Text] [Related]
13. Increasing incidence of abnormal glucose tolerance in women with prior abnormal glucose tolerance during pregnancy: DIAGEST 2 study. Vambergue A, Dognin C, Boulogne A, Réjou MC, Biausque S, Fontaine P. Diabet Med; 2008 Jan; 25(1):58-64. PubMed ID: 18028442 [Abstract] [Full Text] [Related]
14. Unexpectedly high prevalence of pretransplant abnormal glucose tolerance in pediatric kidney transplant recipients. Shishido S, Sato H, Asanuma H, Shindo M, Hataya H, Ishikura K, Hamasaki Y, Goto M, Ikeda M, Honda M. Pediatr Transplant; 2006 Feb; 10(1):67-73. PubMed ID: 16499590 [Abstract] [Full Text] [Related]
15. Long-term follow-up of glucose tolerance function after pancreaticoduodenectomy: comparison between pancreaticogastrostomy and pancreaticojejunostomy. Ishikawa O, Ohigashi H, Eguchi H, Yokoyama S, Yamada T, Takachi K, Miyashiro I, Murata K, Doki Y, Sasaki Y, Imaoka S. Surgery; 2004 Sep; 136(3):617-23. PubMed ID: 15349110 [Abstract] [Full Text] [Related]
16. Glucose disturbances and regulation with glibenclamide in thalassemia. Ladis V, Theodorides C, Palamidou F, Frissiras S, Berdousi H, Kattamis C. J Pediatr Endocrinol Metab; 1998 Sep; 11 Suppl 3():871-8. PubMed ID: 10091160 [Abstract] [Full Text] [Related]
17. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia. Qian L, Fu X, Xu L, Zheng S, Zhou W, Wang X, Gu Y, Lin F, Luo M. Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638 [Abstract] [Full Text] [Related]
19. Should oral glucose tolerance testing be mandatory following acute myocardial infarction? Jessani S, Gangopadhyay K, Patel JV, Lip GY, Millane T. Int J Clin Pract; 2007 Apr; 61(4):680-3. PubMed ID: 17394440 [Abstract] [Full Text] [Related]
20. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF). De Sanctis V, Eleftheriou A, Malaventura C, Thalassaemia International Federation Study Group on Growth and Endocrine Complications in Thalassaemia. Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():249-55. PubMed ID: 16462705 [Abstract] [Full Text] [Related] Page: [Next] [New Search]